Back to FMR LLC

CRNX
6 quarters

Position history for FMR LLC's holdings in CRINETICS PHARMACEUTICALS IN

FMR LLC holds 15.8M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $572.4M as of 2026-Q1. The position was increased (+10.3% shares). CRNX represents 0.0% of FMR LLC's portfolio.

Current Value

$572.4M

Current Shares

15.8M

Total Value Change

+$115.9M

Total Shares Change

+6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
15.8M
+10.3%
$572.4M0.0%$40.12
35
2025-Q4
Increased
14.3M
+0.8%
$665.4M0.0%$47.39
32
2025-Q3
Increased
14.2M
+0.4%
$590.9M0.0%$43.51
32
2025-Q2
Increased
14.1M
+0.7%
$406.3M0.0%$29.96
31
2025-Q1
Increased
14M
+57.2%
$470.6M0.0%$34.73
45
2024-Q4
New
8.9M
-
$456.5M0.0%$50.67
43

Other major holders of CRNX: VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used